Yoon M - Search Results

1

Selective toxicity of tumor treating fields to melanoma: an in vitro and in vivo study.

Jo Y, Hwang SG, Jin YB, Sung J, Jeong YK, Baek JH, Cho JM, Kim EH, Yoon M. Jo Y, et al. Among authors: yoon m. Cell Death Discov. 2018 Oct 3;4:46. doi: 10.1038/s41420-018-0106-x. eCollection 2018. Cell Death Discov. 2018. PMID: 30302280 Free PMC article.

2

Radiotherapy-induced secondary cancer risk for breast cancer: 3D conformal therapy versus IMRT versus VMAT.

Lee B, Lee S, Sung J, Yoon M. Lee B, et al. Among authors: yoon m. J Radiol Prot. 2014 Jun;34(2):325-31. doi: 10.1088/0952-4746/34/2/325. Epub 2014 Apr 4. J Radiol Prot. 2014. PMID: 24705154

3

Risk of secondary cancers from scattered radiation during intensity-modulated radiotherapies for hepatocellular carcinoma.

Kim DW, Chung K, Chung WK, Bae SH, Shin DO, Hong S, Park SH, Park SY, Hong CS, Lim YK, Shin D, Lee SB, Lee HH, Sung J, Yoon M. Kim DW, et al. Among authors: yoon m. Radiat Oncol. 2014 May 8;9:109. doi: 10.1186/1748-717X-9-109. Radiat Oncol. 2014. PMID: 24886163 Free PMC article. Clinical Trial.

4

Estimation of the risk of secondary malignancy arising from whole-breast irradiation: comparison of five radiotherapy modalities, including TomoHDA.

Han EY, Paudel N, Sung J, Yoon M, Chung WK, Kim DW. Han EY, et al. Among authors: yoon m. Oncotarget. 2016 Apr 19;7(16):22960-9. doi: 10.18632/oncotarget.8392. Oncotarget. 2016. PMID: 27027239 Free PMC article.

5

Tumor treating fields inhibit glioblastoma cell migration, invasion and angiogenesis.

Kim EH, Song HS, Yoo SH, Yoon M. Kim EH, et al. Among authors: yoon m. Oncotarget. 2016 Oct 4;7(40):65125-65136. doi: 10.18632/oncotarget.11372. Oncotarget. 2016. PMID: 27556184 Free PMC article.

6

Biological effect of an alternating electric field on cell proliferation and synergistic antimitotic effect in combination with ionizing radiation.

Kim EH, Kim YH, Song HS, Jeong YK, Lee JY, Sung J, Yoo SH, Yoon M. Kim EH, et al. Among authors: yoon m. Oncotarget. 2016 Sep 20;7(38):62267-62279. doi: 10.18632/oncotarget.11407. Oncotarget. 2016. PMID: 27556699 Free PMC article.

7

Secondary cancer-incidence risk estimates for external radiotherapy and high-dose-rate brachytherapy in cervical cancer: phantom study.

Lee B, Ahn SH, Kim H, Son J, Sung J, Han Y, Huh SJ, Kim JS, Kim DW, Yoon M. Lee B, et al. Among authors: yoon m. J Appl Clin Med Phys. 2016 Sep 8;17(5):124-132. doi: 10.1120/jacmp.v17i5.6087. J Appl Clin Med Phys. 2016. PMID: 27685104 Free PMC article.

8

Gold nanoparticles as a potent radiosensitizer in neutron therapy.

Kim EH, Kim MS, Song HS, Yoo SH, Sai S, Chung K, Sung J, Jeong YK, Jo Y, Yoon M. Kim EH, et al. Among authors: yoon m. Oncotarget. 2017 Aug 3;8(68):112390-112400. doi: 10.18632/oncotarget.19837. eCollection 2017 Dec 22. Oncotarget. 2017. PMID: 29348833 Free PMC article.

9

Functional Biological Activity of Sorafenib as a Tumor-Treating Field Sensitizer for Glioblastoma Therapy.

Jo Y, Kim EH, Sai S, Kim JS, Cho JM, Kim H, Baek JH, Kim JY, Hwang SG, Yoon M. Jo Y, et al. Among authors: yoon m. Int J Mol Sci. 2018 Nov 21;19(11):3684. doi: 10.3390/ijms19113684. Int J Mol Sci. 2018. PMID: 30469352 Free PMC article.

10

Effectiveness of a Fractionated Therapy Scheme in Tumor Treating Fields Therapy.

Jo Y, Sung J, Jeong H, Hong S, Jeong YK, Kim EH, Yoon M. Jo Y, et al. Among authors: yoon m. Technol Cancer Res Treat. 2019 Jan 1;18:1533033819845008. doi: 10.1177/1533033819845008. Technol Cancer Res Treat. 2019. PMID: 31072204 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,330 results

Search Page

Filters